Ask AI
Muscarinic in Schizophrenia PC
Beyond the Podium: Continuing the Q&A on Schizophrenia

Released: January 13, 2026

Activity

In this podcast episode, Dr Jonathan Meyer answers additional questions from learners at our Psychopharmacology Update conference. Questions explore other disease states where psychosis can occur, practical considerations around special populations, tolerability, drug combinations, and the potential future of muscarinic-based therapies. For additional activities in this program including a ClinicalThought commentary, a CME/CE/CPE certified on-demand webcast and a downloadable slideset, go to: https://deceraclinical.com/education/program/psychiatry/understanding-muscarinic-acetylcholine-receptors/52399